Potentially false Overinterpreted Certainty of evidence: moderate provisional C-ABX-03

The AMR death toll exceeds HIV and malaria combined.

In short: Overstated: in 2019 AMR caused (was attributable to) an estimated 1.27 million deaths, more than HIV or malaria separately but fewer than the about 1.51 million from both combined; only the broader 'associated' count exceeds both.
Conclusion: Overstated: AMR-attributable deaths exceeded HIV and malaria separately, but not combined (1.27 vs about 1.51 million in 2019).

Original statement

رقم تجاوز ضحايا الإيدز والملاريا معاً

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

The AMR death toll exceeds HIV and malaria combined.

Origin

Source status
Archive editors
Attribution
Archive editors (eltayebat.com)
Origin
https://eltayebat.com/rule/antibiotic-overuse/
Attribution uncertainty
Archive editorial narrative and featured-study cards, written by the archive operators; study selection is the archive's, not necessarily Elawady's.
Population concerned

Global

Geographic restriction by Elawady

none found

Scientific assessment

Potentially false – The available evidence tends to speak against the statement, but is not conclusive.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

AMR deaths exceed HIV and malaria combined.

2. What is demonstrably correct?

AMR-attributable deaths (1.27 million) were ranked ahead of HIV (864,000) and of malaria (643,000) as individual causes (A-ABX-18, I-ABX-132, I-ABX-133). The 4.95 million AMR-associated deaths exceed both combined.

3. What is wrong or exaggerated?

The source says 'ahead of both HIV and malaria', i.e. each separately. Using deaths caused by resistance (attributable), AMR (1.27 million) is below HIV plus malaria combined (about 1.51 million, GBD 2019). The 'associated' count is not a fair comparison, because many of those deaths would also have occurred with a susceptible infection.

4. What remains unclear?

The uncertainty intervals of the attributable AMR estimate (0.911-1.71 million) and of the combined HIV and malaria estimates overlap.

5. Which studies support it?

Partly: AMR-attributable deaths ranked ahead of HIV and ahead of malaria as individual causes; AMR-associated deaths (4.95 million) exceed both combined (A-ABX-18).

6. Which studies contradict it?

A-ABX-18 (wording: 'ahead of both', not 'combined'); I-ABX-132 (GBD 2019: 864,000 HIV deaths) and I-ABX-133 (GBD 2019: 643,000 malaria deaths) - together about 1.51 million, more than the 1.27 million AMR-attributable deaths.

7. What applies to Germany and Europe?

Not region-specific (global comparison).

8. What is known about Egypt?

Not region-specific; for the WHO Eastern Mediterranean Region, which includes Egypt, an estimated 92,800 deaths were attributable to AMR in 2021 (I-ABX-02).

9. What practical conclusion is appropriate?

Use the source's wording: AMR is a leading cause of death, ranking above HIV and above malaria.

Assessment details

Rationale for certainty of evidence

Tested with like-for-like GBD 2019 estimates: HIV 864,000 deaths (I-ABX-132) plus malaria 643,000 deaths (I-ABX-133) = about 1.51 million, more than the 1.27 million AMR-attributable deaths (A-ABX-18); only the broader 4.95 million AMR-associated deaths exceed the combined total. The source itself compares AMR with HIV and malaria separately. Uncertainty intervals overlap, so the verdict is 'potentially false' rather than 'false'.

Source quality

Archive editorial addition.

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Overinterpreted – A real finding exists, but the claim draws more from it than the data allow (e.g. association taken as cause, animal data applied to humans, small effect presented as large).

Research question: In 2019, did deaths from bacterial AMR exceed the combined deaths from HIV and malaria?

Research question in detail (PECO)
Population
Global population, 2019
Intervention or exposure
AMR (associated and attributable deaths)
Comparison
HIV deaths + malaria deaths (GBD 2019)
Geographic scope
Global
Outcomes
  • Death counts

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

  • Global deaths from antibiotic resistance (2019)

    Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0 Risk assessmentfull text checked

    GBD 2019 AMR analysis.

    Actual result
    AMR-attributable deaths would rank 12th, 'ahead of both HIV and malaria'; authors call AMR 'at least as large as major diseases such as HIV and malaria, and potentially much larger'. 4.95 million associated deaths exceed HIV+malaria.
    Methodological quality
    high (modelling)
    Relevance
    direct for the individual comparisons; the associated count supports 'combined' only with an inappropriate comparison
    Limitations
    Associated deaths are not deaths caused by resistance.

    Original publication

What speaks against the claim?

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

With the same GBD 2019 framework, HIV (864,000) plus malaria (643,000) = about 1.51 million deaths, more than the 1.27 million AMR-attributable deaths. Only the much broader 'associated' count (4.95 million) exceeds the combined total. The source itself compares AMR with HIV and malaria separately.

Why some studies weigh more

Same-framework GBD estimates are weighted most; associated deaths are not the right comparator because many of those people would have died of the infection even if it had been susceptible.

Is a causal relationship established? Not applicable Comparison of estimates.

Remaining uncertainty

Uncertainty intervals overlap (attributable 0.911-1.71 million vs combined about 1.43-1.64 million), so the attributable comparison is not decisive; the point estimates say 'lower'.

Justified conclusion

The 'combined' wording overstates the source; 'ahead of HIV and ahead of malaria, each separately' is correct.

Why do studies seem to disagree?

Different counterfactuals (associated vs attributable) explain the apparent support; other sources (UNAIDS/WHO) give lower HIV and malaria counts, but the like-for-like GBD comparison is the fairest.

Does this depend on the country?
General biological effects
Not a biological question.
Eating habits
Not applicable (medicine use, not diet).
Legal rules
Not applicable.
Actual monitoring data
Not applicable.

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • AMR vs HIV+malaria (GBD 2019 point estimates) – Attributable/combined = 0.84; associated/combined = 3.28; attributable vs HIV 1.47x, vs malaria 1.98x; intervals overlap. recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
Comparison of 2019 death estimates
Starting level
low (observational studies)
Reasons for downgrading
  • imprecision (overlapping uncertainty intervals)
Result
moderate

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026TITLE:"burden and control of the HIV epidemic, 1990-2019"contradicting evidence1
Europe PMC26 October 2026TITLE:(malaria) AND TITLE:("2000-2019" OR "2000–2019" OR "2019") AND TITLE:(burden OR mortality OR "Global")contradicting evidence22
Web (curl, PMC web page of A-ABX-18)26 October 2026https://pmc.ncbi.nlm.nih.gov/articles/PMC8841637/ (search for 'HIV' and 'malaria')supporting evidence1

Open questions

A formal GBD comparison of AMR with HIV+malaria including correlated uncertainty.

How deeply was this checked?

3 linked studies: 1 checked in full text (0 of them with a structured risk-of-bias assessment), 2 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: Potentially false (low)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Verdict changed: Potentially false (low) → Potentially false (moderate)
    Verdict unchanged. Certainty raised because the previously missing comparator numbers (GBD 2019 HIV 864,000; malaria 643,000) are now verified; on a like-for-like basis the 'combined' statement is not supported for attributable deaths, while the overlap of uncertainty intervals prevents a firmer verdict.
    New sources: I-ABX-132 I-ABX-133

In plain language

The archive says antibiotic resistance kills more people than HIV and malaria combined. In 2019, resistance directly caused an estimated 1.27 million deaths. That is more than HIV (about 864,000) or malaria (about 643,000) alone, but less than both together (about 1.5 million). Only a much broader count of deaths in which resistant bacteria were involved (4.95 million) is higher than both together.

Studies on this claim

Studies supporting the claim (0)

No studies in this group.

Studies contradicting or limiting the claim (3)

  • Global deaths from antibiotic resistance (2019)

    Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
    Risk assessmentcited by the Tayebat archivefull text checked★ key study

    About 1.27 million deaths were directly caused by resistant bacteria in 2019.

    Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Estimate AMR burden.

    How was the study done?

    Global modelling.

    How many people, animals or samples were studied?

    471 million records.

    What was actually found?

    1.27 M attributable, 4.95 M associated deaths.

    How large was the observed effect?

    Regional rates 6.5-27.3/100,000.

    What do the results mean in everyday life?

    Resistance is a leading killer.

    What are the study's limitations?

    Model estimates.

    What does it say about Elawady's specific claim?

    Supports burden claim; not 'combined'.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Exact counts.

    Scientific details →

  • HIV killed about 864,000 people in 2019 (GBD)

    GBD 2019 HIV Collaborators. Lancet HIV 2021 · PMID 34592142 · DOI 10.1016/S2352-3018(21)00152-1
    Otherindependent cross-checkabstract checked

    The GBD study estimated 864,000 HIV deaths worldwide in 2019.

    864,000 HIV deaths in 2019 -> with malaria about 1.51 million, above 1.27 million AMR-attributable

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Estimate the global HIV burden

    How was the study done?

    Global Burden of Disease model

    How many people, animals or samples were studied?

    204 countries

    What was actually found?

    864,000 deaths in 2019

    How large was the observed effect?

    786,000-996,000

    What do the results mean in everyday life?

    Needed to compare causes of death

    What are the study's limitations?

    Model estimates

    What does it say about Elawady's specific claim?

    Shows the 'combined' comparison does not hold for attributable deaths

    Do the results apply to Germany and Europe?

    Not applicable

    What can explicitly not be concluded from this study?

    Exact ranking given uncertainty

    Scientific details →

  • Malaria killed about 643,000 people in 2019 (GBD)

    Shi D et al.. Risk Manag Healthc Policy 2023 · PMID 37396933 · DOI 10.2147/RMHP.S419616
    Otherindependent cross-checkabstract checked

    GBD-based estimate of 643,000 malaria deaths worldwide in 2019.

    643,000 malaria deaths (GBD 2019)

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Describe malaria trends

    How was the study done?

    Secondary analysis of GBD 2019

    How many people, animals or samples were studied?

    Global

    What was actually found?

    643,000 deaths in 2019

    How large was the observed effect?

    Not applicable

    What do the results mean in everyday life?

    Needed for the comparison

    What are the study's limitations?

    No uncertainty interval in abstract

    What does it say about Elawady's specific claim?

    Shows the 'combined' comparison fails for attributable deaths

    Do the results apply to Germany and Europe?

    Not applicable

    What can explicitly not be concluded from this study?

    Exact ranking

    Scientific details →

Studies with mixed or unclear results (0)

No studies in this group.

Regional context

Germany / EU

Not region-specific (global comparison).

Egypt

Not region-specific; for the WHO Eastern Mediterranean Region, which includes Egypt, an estimated 92,800 deaths were attributable to AMR in 2021 (I-ABX-02).

What applies in my country?

General scientific assessment

Potentially false Overstated: AMR-attributable deaths exceeded HIV and malaria separately, but not combined (1.27 vs about 1.51 million in 2019).

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.. Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
  2. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.. GBD 2019 HIV Collaborators. Lancet HIV 2021 · PMID 34592142 · DOI 10.1016/S2352-3018(21)00152-1
  3. Trends of the Global, Regional and National Incidence, Mortality, and Disability-Adjusted Life Years of Malaria, 1990-2019: An Analysis of the Global Burden of Disease Study 2019.. Shi D et al.. Risk Manag Healthc Policy 2023 · PMID 37396933 · DOI 10.2147/RMHP.S419616

← Back to overview